lifestyle.newsblaze.com

Author: Pyxis Oncology

Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

April 17, 2026
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

March 23, 2026
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity

February 3, 2026